182 related articles for article (PubMed ID: 20481176)
1. Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children.
Johnson PN; Harrison D; Allen C
J Opioid Manag; 2010; 6(2):117-24. PubMed ID: 20481176
[TBL] [Abstract][Full Text] [Related]
2. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children.
Johnson PN; Boyles KA; Miller JL
Pharmacotherapy; 2012 Feb; 32(2):148-57. PubMed ID: 22392424
[TBL] [Abstract][Full Text] [Related]
3. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.
Honey BL; Benefield RJ; Miller JL; Johnson PN
Ann Pharmacother; 2009 Sep; 43(9):1506-11. PubMed ID: 19690220
[TBL] [Abstract][Full Text] [Related]
4. Enteral methadone to expedite fentanyl discontinuation and prevent opioid abstinence syndrome in the PICU.
Lugo RA; MacLaren R; Cash J; Pribble CG; Vernon DD
Pharmacotherapy; 2001 Dec; 21(12):1566-73. PubMed ID: 11765307
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of initial methadone dosing for prevention of iatrogenic opioid abstinence syndrome in children.
Johnson PN; Miller J; Harrison D
J Pediatr Intensive Care; 2012 Jun; 1(2):105-113. PubMed ID: 31214394
[TBL] [Abstract][Full Text] [Related]
6. Opioid withdrawal in critically ill neonates.
Dominguez KD; Lomako DM; Katz RW; Kelly HW
Ann Pharmacother; 2003 Apr; 37(4):473-7. PubMed ID: 12659598
[TBL] [Abstract][Full Text] [Related]
7. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a six-hour continuous overlap method for converting intravenous to transdermal fentanyl in cancer pain.
Samala RV; Bloise R; Davis MP
J Pain Symptom Manage; 2014 Jul; 48(1):132-6. PubMed ID: 24291296
[TBL] [Abstract][Full Text] [Related]
9. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.
Mystakidou K; Befon S; Tsilika E; Dardoufas K; Georgaki S; Vlahos L
Oncology; 2002; 62(1):9-16. PubMed ID: 11810038
[TBL] [Abstract][Full Text] [Related]
10. Postoperative analgesia with parenteral opioids: does continuous delivery utilizing a transdermal opioid preparation affect analgesic efficacy or patient safety?
Sevarino FB; Paige D; Sinatra RS; Silverman DG
J Clin Anesth; 1997 May; 9(3):173-8. PubMed ID: 9172021
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of transdermal fentanyl initiation in Australian clinical practice.
Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L
Eur J Clin Pharmacol; 2019 Mar; 75(3):401-408. PubMed ID: 30392109
[TBL] [Abstract][Full Text] [Related]
12. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.
Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA
Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children.
Darnell CM; Thompson J; Stromberg D; Roy L; Sheeran P
Pediatrics; 2008 May; 121(5):e1363-71. PubMed ID: 18411237
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal symptom after discontinuation of transdermal fentanyl at a daily dose of 0.6 mg.
Ishihara C; Konishi H; Chiba M; Minouchi T; Endo Y; Yamaji A
Pharm World Sci; 2005 Feb; 27(1):13-5. PubMed ID: 15861929
[TBL] [Abstract][Full Text] [Related]
15. Methadone dosage for prevention of opioid withdrawal in children.
Siddappa R; Fletcher JE; Heard AM; Kielma D; Cimino M; Heard CM
Paediatr Anaesth; 2003 Nov; 13(9):805-10. PubMed ID: 14617122
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. Analgesia and Sedation Protocol for Mechanically Ventilated Postsurgical Children Reduces Benzodiazepines and Withdrawal Symptoms-But Not in All Patients.
Neunhoeffer F; Seitz G; Schmidt A; Renk H; Kumpf M; Fideler F; Esslinger M; Gerbig I; Fuchs J; Hofbeck M
Eur J Pediatr Surg; 2017 Jun; 27(3):255-262. PubMed ID: 27454068
[No Abstract] [Full Text] [Related]
19. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU.
Tobias JD
J Opioid Manag; 2006; 2(4):201-5. PubMed ID: 17319480
[TBL] [Abstract][Full Text] [Related]
20. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine.
Vielvoye-Kerkmeer AP; Mattern C; Uitendaal MP
J Pain Symptom Manage; 2000 Mar; 19(3):185-92. PubMed ID: 10760623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
